|
Barr Confirms Filing an Application With a Paragraph IV Certification for Patanol Ophthalmic Solution, 0.1 Percent
Barr Pharmaceuticals, Inc. confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Alcon, Inc. in connection with Alcon’s Patanol (olopatadine hydrochloride ophthalmic solution) 0.1 percent. |
Register Now
Archives